Brand Names : Zenapax, dacliximab
- monoclonal antibody
belongs to a group of medicines known as immunosuppressive agents. It is used
to lower the body's natural immunity in patients who receive kidney transplants.
When a patient receives a kidney transplant, the body's white blood cells
will try to get rid of (reject) the transplanted kidney. Daclizumab works
by preventing the white blood cells from getting rid of the transplanted kidney.
The effect of daclizumab on the white blood cells may also reduce the body's
ability to fight infections.
Daclizumab is to be administered only by or under the immediate supervision
of your doctor. It is available in the following dosage form:
Some commonly used brand names are:
In the U.S. -
Another commonly used name is dacliximab